Healthcare -
Biotechnology - NASDAQ - US
$ 8.03
-0.623 %
$ 178 M
Market Cap
-3.68
P/E
INMB - GROSS PROFIT
Gross Profit INMB - INmune Bio, Inc.
155 K
LAST VALUE
-7.46%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR